Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hamza Hashmi
Haemophagocytic Lymphohistiocytosis Has Variable Time to Onset Following CD19 Chimeric Antigen Receptor T Cell Therapy
British Journal of Haematology
Hematology
Choosing the Appropriate Salvage Therapy for B-Cell Non-Hodgkin Lymphoma
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Related publications
Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy
British Journal of Haematology
Hematology
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
Safety of Allogeneic Hematopoietic Cell Transplant in Adults After Cd19 Targeted Chimeric Antigen Receptor-Modified T-Cell (Car-T) Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
International Journal of Hematology
Hematology
Advancing Chimeric Antigen Receptor T Cell Therapy With CRISPR/Cas9
Protein & Cell
Biochemistry
Biotechnology
Drug Discovery
Cell Biology
Medicine
Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Prospects to Improve Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Immunotherapy
Oncology
Allergy
Immunology
169. Clinically Adaptable CD19-Specific Chimeric Antigen Receptor
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery